EE507 Pre-Progression Health State Utility Values From the TALAPRO-2 Clinical Trial in Patients With Metastatic Castration-Resistant Prostate Cancer Unselected for DDR Mutations
Abstract
Authors
A. Niyazov E. Simou M. Kirker K. Houghton J.G. Le Moine J. Chang S. Yarr C. Barnett D.D. Mladsi